New combo therapy aims to knock out stomach bug in thousands
NCT ID NCT07285096
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests different combinations of acid-blocking drugs (P-CABs) with bismuth and antibiotics to treat H. pylori, a stomach infection that can cause ulcers. About 1,730 adults aged 18-70 with confirmed H. pylori will receive one of several treatment regimens. Researchers will track how well each combination clears the infection and any side effects, aiming to find the most effective and safest first-line therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HELICOBACTER PYLORI INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Qilu Hospital of Shandong University
RECRUITINGJinan, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a closer look at the stomach spot hidden infections?
- Which antibiotic combo wins against h. pylori? a Head-to-Head test
- Can customizing antibiotics beat stomach bug resistance?
- A supplement may tame the Gut-Wrenching side effects of h. pylori therapy
- Could a fecal transplant beat a stubborn stomach bug?
- AI eye on stomach cancer: 6,000-Person trial tests smarter scopes